< Back to companies

InnoCC is a spinoff from Innovision, a leading specialist in medical instruments using advanced gas exchange methods for non-invasive cardio-pulmonary measurements. The goal of InnoCC is to develop devices and modules for non-invasive measurement of cardiac output, oxygen uptake, and functional residual capacity. InnoCC is funded by Innovision ApS, Fonden for Syddansk Vækstfremme/Welfare Tech Invest and SEED Capital.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2013
Website
www.innocc.dk

Categories

Cardiovascular DiseasePulmonary/ Asthma
Only accessible to MedStartr community members. Join now

What do you think of InnoCC?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now